Checkpoint inhibitors opened the door; now a new wave of immunotherapy discoveries is poised to turn more cancers into curable diseases. MD Anderson’s Nobel Laureate James Allison – inventor of the first immune checkpoint inhibitor – and immunotherapy pioneer Padmanee Sharma sit down with 21-year, stage-IV cancer survivor Sharon Belvin and veteran TIME journalist Alice Park to chart where the science goes next and what still blocks its path. Attendees will learn how immunotherapy advances are changing the cancer landscape, including technologies to watch and a candid look at obstacles ahead.

See omnystudio.com/listener for privacy information.